Synthesis
AssigneeOncology Research International Limited
InventorsAndrew Clive Muscroft-Taylor, Philip Andrew Marshall, Jennifer Mary Mason, David Millar Walker
Life of this patent
Estimating the term…
Abstract
The present invention provides an improved synthesis of a class of steroid saponins. Furthermore, the present invention provides a method of selectively discriminating between the C2 and C3 hydroxyl groups of a mono-glycosylated steroid saponin—a key step in the preparation of this class of compounds. Additionally, the present invention provides a range of steroid saponin derivatives, and methods of making them.
Claims46
A method for the preparation of a compound of Formula X
- wherein
- R1 is a sapogenin;
- R2, R3, and R4 are each independently an oxygen protecting group;
- R5 is an acyl group;
- R6 and R7 are H;
- R9 is selected from the group consisting of H, CH3, and an oxygen protected by an oxygen protecting group;
- the method comprising
- (i) reacting a compound of Formula A with an acylating agent in an acylation reaction in the presence of a base;
- wherein
- R1 is a sapogenin;
- R6 and R7 are each independently an oxygen protecting group;
- or when taken together form a cyclic di-oxygen protecting group;
- to provide a compound of Formula B
- R1 is sapogenin;
- R5 is an acyl group;
- R6 and R7 are each independently an oxygen protecting group or when taken together form a cyclic di-oxygen protecting group;
- (ii) reacting a compound of Formula B with a compound of Formula C under coupling conditions
- wherein
- R2, R3, and R4 are each independently an oxygen protecting group;
- R8 is a leaving group;
- and
- R9 is selected from the group consisting of H, CH3, and an oxygen protected by an oxygen protecting group;
- (iii) selectively removing the oxygen protecting groups at R6 and R7 to provide a compound of Formula X.
(canceled)
5-6. (canceled)
8-9. (canceled)
12-14. (canceled)
16-18. (canceled)
20-21. (canceled)
(canceled)
A method for the preparation of a compound of Formula Y
- wherein
- R1 is a sapogenin;
- R2, R3, R4, R5 and R7 are each H;
- R6 is H or a saccharide;
- R9 is selected from the group consisting of H, OH and CH3;
- pharmaceutically acceptable salts, isomers, hydrates and solvate thereof;
- the method comprising
- (i) reacting a compound of Formula A with an acylating agent in an acylation reaction in the presence of a base;
- wherein
- R1 is a sapogenin;
- R6 and R7 are each independently an oxygen protecting group;
- or when taken together form a cyclic di-oxygen protecting group;
- to provide a compound of Formula B
- R1 is a sapogenin;
- R5 is an acyl group;
- R6 and R7 are each independently an oxygen protecting group, or when taken together form a cyclic di-oxygen protecting group;
- (ii) reacting a compound of Formula B with a compound of Formula C under coupling conditions
- wherein
- R2, R3, and R4 are each independently an oxygen protecting group;
- R8 is a leaving group;
- and
- R9 is selected from the group consisting of H, CH3, and an oxygen protected by an oxygen protecting group;
- (iii) selectively removing the oxygen protecting groups at R6 and R7 to provide a compound of Formula X
- wherein
- R1 is a sapogenin;
- R2, R3, and R4 are each independently an oxygen protecting group;
- R5 is an acyl group;
- R6 and R7 are H;
- R9 is selected from the group consisting of H, CH3, and an oxygen protected by an oxygen protecting group;
- (iv) converting a compound of Formula X into a compound of Formula Y, pharmaceutically acceptable salts, isomers, hydrates or solvates thereof.
(canceled)
29-30. (canceled)
32-33. (canceled)
36-38. (canceled)
40-42. (canceled)
44-45. (canceled)
(canceled)
50-52. (canceled)
(canceled)
A compound of formula X
- wherein
- R1 is sapogenin;
- R2, R3, and R4 are each independently an oxygen protecting group;
- R5 is an acyl group;
- R6 and R7 are each H;
- R9 is CH3.
Dependencies are inferred from the claim text.